drugset / Trial / NCT06512441

Vitamin B6 Aids in Treating Inflammatory Bowel Disease

NCT06512441

Recruiting 220 enrolled Changhai Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Patients with IBD are randomized to oral administration of VitaminB6 and placebo based on the standard treatment, exploring whether VitaminB6 can increasee the clinical remission rateand improve the treatment effect of IBD patients.

Timeline

Start
2024-06-01
Primary completion
2025-12-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Pyridoxine Unknown 10 mg Oral